
Morgan Stanley’s spot Bitcoin ETF MSBT has seen strong early demand with inflows crossing 100 million dollars within the first few trading days. The fund also recorded about 30.6 million dollars on launch day, showing solid institutional interest. With a low 0.14 percent fee, it has become highly competitive in the Bitcoin ETF market. The strong start highlights growing investor appetite for regulated Bitcoin exposure as competition among major issuers like BlackRock continues to intensify in the digital asset space.
CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.
All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.
Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
Morpho's price has maintained significant strength since the start of 2026, which has kept the…
After experiencing a significant sell-off, the bulls are trying hard to initiate a strong rebound…
The memecoin sector is beginning to show signs of renewed strength after spending months in…
The upcoming CLARITY Act is widely expected to reshape the U.S. crypto market by providing…
After consolidating within a pre-defined range, the Dogecoin price is showing early signs of recovery.…
Avalanche (AVAX) price hovered near $6.65 after climbing more than 3% this week, recovering from…